Breaking news on Acid Reflux and GORD
Orexo Announces Results Confirming The Clinical Profile Of OX17 In Reflux Disease (GERD) published
Fri, 28 Mar 2008 06:00:00 PDT
New clinical data from a phase II study confirms the competitive profile of Orexo's product OX17 in GERD patients, i.e. fast, effective and sustained inhibition of gastric acid production, a prerequisite for effective symptom relief in the patient. The result demonstrates the clinical potential of OX17 and is an important step in the development of a competitive product. GERD, gastroesofageal reflux disease, is a common ailment in the Western world.
New Advice On Treating GERD: Johns Hopkins Health Alerts Reports On The Latest Research published
Fri, 28 Mar 2008 02:00:00 PDT
Johns Hopkins Health Alerts has just published a review of the new GERD guidelines, for safe, effective treatment of your acid reflux. Treating GERD EffectivelyThere are four types of treatments for gastroesophageal reflux disease (GERD): lifestyle measures, medication, surgery, and endoscopic procedures. Why it is important to treat GERDTreating GERD is important.
FDA Approves Nexium For Use In Children Ages 1-11 Years published
Fri, 29 Feb 2008 01:00:00 PDT
The U.S. Food and Drug Administration approved Nexium (esomeprazole magnesium) for short-term use in children ages 1-11 years for the treatment of gastroesophageal reflux disease (GERD). The agency approved Nexium in two forms, a delayed-release capsule and liquid form. Nexium is approved in 10 milligrams (mg) or 20 mg daily for children 1-11 years old compared to 20 mg or 40 mg recommended for pediatric patients 12 to 17 years of age.
EndoGastric Solutions(TM) Announces Results Of EsophyX(TM) Multi-Center GERD Study published
Wed, 27 Feb 2008 02:00:00 PDT
EndoGastric Solutions, the world leader in natural orifice surgery products and procedures, announces outstanding results at the completion of 1-year follow-up on GERD patients in the phase 2 multi-center study of the first generation transoral incisionless fundoplication (TIF 1) procedure and first-generation EsophyX device.
Black Raspberries Protect Against Cancer - New Study Finds Black Raspberries Help Barrett's Esophagus Patients published
Fri, 15 Feb 2008 02:00:00 PDT
It usually starts as reflux, but for 700 thousand Americans, it turns into something called Barrett's Esophagus.* Now the black raspberry may be one of the weapons Barrett's Esophagus patients have to stay strong and prevent the condition from turning into a deadly cancer. For more than 10 years, Danny Harris has struggled with heartburn after he eats. He learned his reflux has turned into something more serious - a condition called Barrett's Esophagus.
Patients Encouraged To See A Physician If They Experience Symptoms Suggestive Of GERD published
Mon, 28 Jan 2008 02:00:00 PDT
A recent study from the Agency for Healthcare Research and Quality shows that hospitalizations for disorders caused by gastroesophageal reflux disease or GERD rose 103 percent between 1998 and 2005. Also, hospitalizations for patients who had milder forms of GERD (in addition to the condition for which they were admitted), rose by 216 percent during the same time period. The numbers underscore the importance of seeing a physician if symptoms suggestive of GERD are present.
Does The Doctor Assess Your Heartburn Correctly? published
Fri, 11 Jan 2008 02:00:00 PDT
A simple scale (None, Mild, Moderate, Severe) is frequently used to grade heartburn severity in clinical trials as well as in clinical practice and the question is whether this scale captures the heartburn severity well enough.
Heartburn Surgery Done Through Patient's Mouth published
Fri, 11 Jan 2008 02:00:00 PDT
If you're constantly reaching for antacids to control your heartburn, you may have a more serious problem called reflux disease. Some 25 million Americans have it* and now they have a new option to treat it. Using a newly-approved device for the first time in the U.S., doctors have performed surgery to fix reflux problems without making a single incision. Developing the technology took decades, but the operation only took an hour.
Hospitalizations For GERD Up By 103 Percent published
Mon, 07 Jan 2008 00:00:00 PDT
Hospitalizations for treating disorders caused by gastroespohageal reflux disease (GERD ) increased by 103 percent between 1998 and 2005, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. During the same period, hospitalizations of patients who, in addition to the ailment for which they were admitted, had milder forms of GERD, rose by 216 percent.
Using Newly Approved Device, Doctors Do "incision-less" GERD Surgery published
Fri, 04 Jan 2008 02:00:00 PDT
If you're constantly reaching for antacids to control your heartburn, you may have a more serious problem called reflux disease. Some 25 million Americans have it* and now they have a new option to treat it. Using a newly-approved device for the first time in the U.S., doctors have performed surgery to fix reflux problems without making a single incision. Developing the technology took decades, but the operation only took an hour.
Acid Reflux Study Looks At Lifespan Of Sufferers published
Fri, 04 Jan 2008 02:00:00 PDT
Gastroesophageal reflux disease (GERD), often known as acid reflux, is a common problem that has been associated with cancers, asthma, recurrent aspiration and pulmonary fibrosis. A new study published in The American Journal of Gastroenterology examines whether GERD sufferers may have shorter lifespans than those without the disease.
Hospitalizations Due To GERD Rose 103% Between 1998 And 2005, USA published
Fri, 04 Jan 2008 02:00:00 PDT
The number of people hospitalized because of GERD (gastroesophageal reflux disease) in the USA rose 103% between the period 1998 and 2005, according to details published by the Agency for Healthcare Research and Quality (AHRC). During that same period there was a 216% rise in the number of patients hospitalized for other ailments but who also had milder forms of GERD. A person who suffers GERD experiences chronic heartburn because stomach acid backs up into the esophagus.
£100m Spent Annually On Pointless Indigestion Drugs By NHS published
Fri, 04 Jan 2008 00:00:00 PDT
It is estimated that the National Health Service (NHS) spends at least £100m per year on needless indigestion drugs, according to an editorial published in the British Medical Journal (BMJ). The UK is not alone in this kind of spending - apparently, almost £2bn are spent globally on such drugs each year. Two gastroenterology doctors at King's College Hospital, London, write that proton pump inhibitors are the most commonly prescribed classes of drug worldwide.
ASGE Offers Guidelines On Endoscopic Treatment Of Dyspepsia published
Mon, 24 Dec 2007 01:00:00 PDT
The American Society for Gastrointestinal Endoscopy (ASGE) has issued guidelines for the role of endoscopy in treating dyspepsia, discomfort thought to arise from the upper-gastrointestinal tract, which affects a fourth of the population in Western countries. An upper endoscopy is a procedure which uses an instrument to evaluate the inside of the esophagus, stomach and small intestine.
Astrazeneca Receives First European Approval For Nexium(R) In Pediatric Gerd published
Fri, 30 Nov 2007 02:00:00 PDT
AstraZeneca announced that it has received Swedish Medical Products Agency (MPA) approval for use of Nexium(R) (esomeprazole) in children aged 1-11 years with gastroesophageal reflux disease (GERD) in the reference member state of Sweden, with other European Union nations expected to follow.1 Nexium® will become the first of the proton pump inhibitors (PPI) currently available for the treatment of pediatric GERD to have a specific formulation developed for children.
Wyeth Receives FDA Approval Of Protonix For Delayed Release Oral Suspension published
Sun, 18 Nov 2007 00:00:00 PDT
Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), announced that the U.S. Food and Drug Administration (FDA) has approved Protonix® (pantoprazole sodium) For Delayed-Release Oral Suspension, a new addition to the Protonix family of prescription medications.
Survey Reveals Heartburn Sufferers Experience More Heartburn During The Holidays published
Wed, 14 Nov 2007 00:00:00 PDT
Heartburn remains a burning problem for more than 60 million Americans each month(1), and this November, the National Heartburn Alliance (NHBA) is recognizing the need for heartburn education by sponsoring the first ever Heartburn Awareness Month. Recent survey results show that 66% of people experience heartburn symptoms during the holiday season.
Night-Time Acid Reflux Can Impact Sleep, New Studies Reveal published
Tue, 16 Oct 2007 06:00:00 PDT
According to results of a survey presented at the 72nd Annual Scientific Meeting of the American College of Gastroenterology, nighttime acid reflux, along with some of the less typical manifestations or symptoms of gastroesophageal reflux disease (GERD), is associated with significant sleep impairment.
Little Known, But Potentially Serious, Manifestations Of Acid Reflux Highlighted By Studies published
Tue, 16 Oct 2007 06:00:00 PDT
GERD can masquerade as persistent cough or even severe chest painMany people may not realize that symptoms such as chronic cough or chest pain can be caused by acid reflux into the esophagus, because they do not experience classic heartburn symptoms or acid regurgitation. Two new studies presented at the 72nd ACG Annual Scientific Meeting highlight the little known connection between gastroesophageal reflux and seemingly unrelated problems.
Frequency Of Transient Lower Esophageal Sphincter Relaxation May Be Decreased By Electroacupuncture At PC6 published
Thu, 11 Oct 2007 03:00:00 PDT
The First Hospital of Peking University, China-Research, has shown that electroacupuncture at PC6 may decrease the frequency of transient lower esophageal sphincter relaxation (TLESR), which is the main mechanism underlying gastroesophageal reflux disease (GERD). The study is reported in Issue 35 of the World Journal of Gastroenterology because of its significant clinical impact.
Transcutaneous Cervical Esophageal Ultrasound Can Not Substitute For 24-h PH Monitoring Or Manometry published
Wed, 10 Oct 2007 05:00:00 PDT
24-h pH monitoring and esophageal manometry are the gold standards of methods used for diagnosing GER and esophageal motor disorders, respectively. Intraluminal refluxate can be recognized by US images. Sonographic GER diagnosis is made by backward movement of gastric content into the esophagus and the visualization of the clearance of refluxate material. Postprandial refluxate was seen in 45 of 500 (9%) adults. GER and/or manometric pathology was found in 71.
NDO Receives FDA 510(K) Clearance For Plicator II(TM) published
Fri, 21 Sep 2007 00:00:00 PDT
NDO Surgical, Inc. (NDO) announced that the US Food and Drug Administration (FDA) cleared the Company's Plicator II(TM) multiple implant technology for immediate sale and distribution. Plicator II technology offers improved outcomes for harder-to-treat gastroesophageal reflux disease (GERD) patients.
Correlation Discovered Between GERD And Obesity In Females published
Tue, 18 Sep 2007 01:00:00 PDT
A group of scientists recently discovered an association between being overweight and a disease called gastro-esophageal reflux disease (GERD) in women.This discovery was published in the Sept. 14 issue of the World Journal of Gastroenterology by a research group led by Dr. Corazziari from the University La Sapienza of Rome. Dr. Corazziari has been a leader in the field of gastroenterology for a long time and published over 200 research articles and 20 professional books.
It's Only Heartburn...or Is It? Chronic Heartburn A Risk Factor For Precursor To Esophageal Cancer published
Wed, 12 Sep 2007 00:00:00 PDT
If you have or have ever had chronic heartburn, you may be at risk for Barrett's esophagus, a serious complication of chronic, severe gastroesophageal reflux disease (GERD). Barrett's esophagus has been recognized as a major risk factor for developing cancer of the esophagus, the seventh deadliest cancer in men in the United States.
Brain-Gut Relationship Studied In Those Suffering With Stomach Pain Or Discomfort published
Sun, 09 Sep 2007 20:00:00 PDT
A new clinical study will explore the brain-gut interaction in patients with functional dyspepsia and whether certain drugs can effectively relieve symptoms of this disorder. Functional dyspepsia is a costly and chronic disorder that can cause severe stomach pain often reported as cramping, bloating, and gas, or great discomfort or fullness after eating. The study is funded by the National Institutes of Health (NIH) at six medical centers in the U.S.
|
|
